TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind

Trial Profile

TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 22 Apr 2017

At a glance

  • Drugs Fluorine 18 THK 5351 (Primary)
  • Indications Alzheimer's disease; Diabetes mellitus
  • Focus Diagnostic use
  • Acronyms TAUPET
  • Most Recent Events

    • 17 Apr 2017 Planned initiation date changed from 1 Feb 2017 to 1 Jun 2017.
    • 23 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top